- Fee assured
- Verified this account
Dr Dungarwalla is a haematology specialist and the Clinical Director for Cancer Services at Milton Keynes NHS Foundation Trust. He specialises in the diagnosis and treatment of blood disorders.
Dr Dungarwalla qualified in Medicine from Imperial College School of Medicine graduating with Honours in 2000. He trained in Internal Medicine and subsequently completed his specialist training in Haematology at the Royal Marsden Hospital in London.
Areas of interest
Leukaemia; Lymphoma; Myeloma; Anaemia; Thrombosis, Bleeding disorders; Thrombophilia; Myelodysplasia
- Liliana Ricci
- GenesisCare Sunrise Parkway Linford Wood East Milton Keynes MK14 6LS
- 01908 467704
- 01908 238415
Current NHS consultant posts held
Consultant Haematologist Milton Keynes NHS Foundation Trust
Lead Cancer Clinician Milton Keynes NHS Foundation Trust
Dr Dungarwalla has published research in various publications. His areas of interest include:
Advanced refractory chronic lymphocytic leukemia.
Autoimmune neutropenia and pure red cell aplasia.
Prothchronic lymphocytic leukemia (CLL).
Prolymphocytic leukaemias of B and T cell subtype.
Splenic marginal zone lymphoma (SMZL).
- MBBS Imperial College School of Medicine 2000
- MRCP Royal College of Physicians London 2003
- FRCPath Royal College of Pathologists London 2007
Reference number 4737230
Professional bodies (positions held - last 3 yrs)
- Clinical Director Cancer Services Milton Keynes NHS Foundation Trust 2012
Details of entry to specialist register
- Haematology, 2008
- BMI The Saxon Clinic, MK6 5LR
- 18:00 - 21:00
- 01908 243502
- Genesis Care Milton Keynes, MK14 6LS
- 17:00 - 19:00
- 01908 243502
Post treatment communication
Following treatment of a Bupa member, I will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.
Information for healthcare professionals (Bupa patients only, last 12 months)
Clinical supervision and planning for delivery of chemotherapy cycle 1 - 28 days - (>50)
Therapeutic venesection - (5-50)
Intravenous infusion (as sole procedure) - (5-50)
Diagnostic aspiration and trephine biopsy of bone marrow, including analysis - (5-50)
Clinical supervision and planning for delivery of chemotherapy cycle 1 - 21 days - (5-50)
- Show All (7)...